Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Dyadic International Inc. DYAI

Dyadic International Inc is a biotechnology company engaged in the discovery, development, manufacturing and selling of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:DYAI)

Fundamentals Snapshot (NDAQ:DYAI)

Opinion & Analysis (NDAQ:DYAI)

No current opinion is available.

Bullboard Posts (NDAQ:DYAI)

4 PROMISING BIOTECH STOCKS WITH IMMENSE POTENTIAL!

$DYAI $BCRX $IPSC $CDNA   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of...
AviseAnalytics - January 14, 2022

RE:Roadshow Replay from this week.

JfI I EXITED DYAI. "Basically Nothing against" DYAI, I "just need some Room for Others".
Popeye82 - May 29, 2021

Reddit user Price Target $TSF...$9.65

$TSF...Lets make money together.... Read the Article... https://t.co/qJXe5DYmlz?amp=1
Shonv320000000 - January 27, 2021

Roadshow Replay from this week.

https://www.channelchek.com/channelcast-detail/182   DYAI
SmallCapPaul - October 17, 2020

TODAY - Virtual Roadshow with Dyadic CEO Mark Emalfarb

TODAY - meet with Dyadic President & CEO Mark Emalfarb. Tune in, ask questions, no charge https://attendee.gotowebinar.com/register...
schoolofrock - October 14, 2020

Dyadic Updates Market on COVID-19 Initiatives

Dyadic's C1 Rapid Recombinant Protein Manufacturing Platform has demonstrated that it can manufacture monoclonal antibodies (mAbs...
schoolofrock - October 12, 2020